CEVI — CellaVision AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for CellaVision AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	102	102	130	108	122
Net Total Accounts Receivable
Net Total Receivables	103	106	114	120	110
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	265	298	365	377	366
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	54.5	47.4	80.3	110	126
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	642	668	825	892	929
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	126	104	135	133	119
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	293	238	282	250	212
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	348	430	543	642	716
Total Liabilities & Shareholders' Equity	642	668	825	892	929
Total Common Shares Outstanding